MRD / Regn No. : 20160000785 Date : 29/06/2026
Patient Name : Gurumoorthy Dilli Naidu Age & Gender : 59 Yrs. / Male
Contact No. : 9444505898 UHID :
Ht / Wt / BMI : 168 / 87.4 / 30.97 BP S / BP D : 126 / 84
Allergies : NKA Referred By :
   
Problem List : VITAMIN D DEFICIENCY (24/Apr/2018) | HYPERTENSION (24/Apr/2018) | TYPE 2 DM (01/Jan/2016) | BENIGN PROSTATIC HYPERPLASIA (01/Jan/2016) | PARAPHIMOSIS (15/Jul/2022) | HFPEF (25/Aug/2022) | PRIMARY PULMONARY HYPERTENSION (02/Jul/2025) | OBSTRUCTIVE SLEEP APNEA (02/Jul/2025) |
Subjective : DIAGNOSED WITH PRIMARY PULMONARY HYPERTENSION,FOLLOWING UP WITH PULMONOLOGIST,UNABLE TO HANDLE FULL DOSE OF WEGOVY
Objective : 6 KG WEIGHT LOSS
Analysis : T2DM IMPROVED,GU INFECTION WITH SGLT2I,HEART FAILURE STAGE B,OBSTRUCTIVE SLEEP APNEA
Plan : DECREASE SEMAGLUTIDE TO 1.7 MG  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 88.4 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 58.8 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TERAZOSIN 1 MG
HYTRIN 1
Medicine For PROSTATE
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
2 RAMIPRIL 5 MG
CARDACE 5 MG
Medicine For HYPERTENSION KIDENY PROTECTION
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE DRY COUGH
3 ROSUVASTATIN 10 MG
CRESTOR 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY
4 INJECTION SEMAGLUTIDE 1.7 MG
WEGOVY 1.7 MG
Medicine For DIABETES OBESITY
SQ Q WEEKLY AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA AND VOMITING
       
Refill : 0 / Substitution:    
Education :
Next Visit : 28/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: